+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

University of Texas MD Anderson Cancer Center - Strategic SWOT Analysis Review

  • PDF Icon

    SWOT Analysis

  • 48 Pages
  • July 2024
  • Region: United States
  • GlobalData
  • ID: 4377318
University of Texas MD Anderson Cancer Center - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - The analyst’s summarization of the company’s business strategy.
  • SWOT analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list of key locations and subsidiaries of the company, including contact details.

Highlights

University of Texas MD Anderson Cancer Center (MD Anderson) is a cancer care center. It offers cancer treatment, cancer research, education, and research-based prevention of both common and rare cancers in adult and pediatric patients. The company's major departments include cancer biology, cancer medicine, cancer systems imaging, cancer prevention and population sciences, clinical cancer prevention, general oncology, hematopathology, gastroenterology, hepatology and nutrition, and genitourinary medical oncology, among others. MD Anderson offers graduate, undergraduate, and post-graduate programs, besides research training and nursing education. It operates various research centers, labs and facilities across Texas, New Mexico and New Jersey, the US; among others. MD Anderson is headquartered in Houston, Texas, the US.

University of Texas MD Anderson Cancer Center Key Recent Developments

  • Jun 20, 2024: CAR NK Cells with CD28 Costimulation Improved Cell Persistence and Antitumor Activity
  • Jun 05, 2024: New Clinical Research Provides Evidence that Proton Therapy Offers Significant Patient Benefits for Head and Neck Cancer Treatment
  • Jun 04, 2024: ASCO: Proton Therapy Demonstrates Advantages in Phase III Head and Neck Cancer Trial
  • Jun 01, 2024: ASCO: Novel Targeted Cancer Therapies Demonstrate Activity and Safety in Metastatic Solid Tumors

Reasons to Buy

  • Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
  • Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
  • Understand and respond to your competitors’ business structure and strategies with the analyst’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
  • Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
Note: Some sections may be missing if data is unavailable for the company.

Table of Contents

Section 1 - About the Company
  • University of Texas MD Anderson Cancer Center - Key Facts
  • University of Texas MD Anderson Cancer Center - Key Employees
  • University of Texas MD Anderson Cancer Center - Key Employee Biographies
  • University of Texas MD Anderson Cancer Center - Major Products and Services
  • University of Texas MD Anderson Cancer Center - History
  • University of Texas MD Anderson Cancer Center - Company Statement
  • University of Texas MD Anderson Cancer Center - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
  • Joint Venture
Section 2 - Company Analysis
  • Company Overview
  • University of Texas MD Anderson Cancer Center - Business Description
  • Business Segment: Auxiliary Income
  • Performance
  • Business Segment: Grants and Contracts
  • Performance
  • Business Segment: Net Patient Revenue
  • Performance
  • Business Segment: Net Sales and Services of Educational Activities
  • Performance
  • Business Segment: Other Income
  • Performance
  • R&D Overview
  • University of Texas MD Anderson Cancer Center - Corporate Strategy
  • University of Texas MD Anderson Cancer Center - SWOT Analysis
  • SWOT Analysis - Overview
  • University of Texas MD Anderson Cancer Center - Strengths
  • University of Texas MD Anderson Cancer Center - Weaknesses
  • University of Texas MD Anderson Cancer Center - Opportunities
  • University of Texas MD Anderson Cancer Center - Threats
  • University of Texas MD Anderson Cancer Center - Key Competitors
  • University of Texas MD Anderson Cancer Center, Recent Deals Summary
Section 3 - Company’s Recent Developments
  • Jun 20, 2024: CAR NK Cells with CD28 Costimulation Improved Cell Persistence and Antitumor Activity
  • Jun 05, 2024: New Clinical Research Provides Evidence that Proton Therapy Offers Significant Patient Benefits for Head and Neck Cancer Treatment
  • Jun 04, 2024: ASCO: Proton Therapy Demonstrates Advantages in Phase III Head and Neck Cancer Trial
  • Jun 01, 2024: ASCO: Novel Targeted Cancer Therapies Demonstrate Activity and Safety in Metastatic Solid Tumors
  • May 31, 2024: ASCO: Novel CAR TTherapy and Shorter Targeted Therapy Durations Show Promise for Patients With Leukemia
  • May 23, 2024: MD Anderson Research Highlights: ASCO 2024 Special Edition
  • May 21, 2024: MD Anderson Research Highlights for May 21, 2024
  • May 16, 2024: End-of-Life Systemic Treatment for Patients with Advanced Cancers Does Not Improve Survival
  • May 08, 2024: MD Anderson Research Highlights for May 8, 2024
  • May 01, 2024: MD Anderson and Pan American Health Organization Join Forces to Support Cancer Prevention and Control in the Americas
Section 4 - Appendix
  • Methodology
  • About the Analyst
  • Contact the Publisher
  • Disclaimer
List of Tables
  • University of Texas MD Anderson Cancer Center, Key Facts
  • University of Texas MD Anderson Cancer Center, Key Employees
  • University of Texas MD Anderson Cancer Center, Key Employee Biographies
  • University of Texas MD Anderson Cancer Center, Major Products and Services
  • University of Texas MD Anderson Cancer Center, History
  • University of Texas MD Anderson Cancer Center, Subsidiaries
  • University of Texas MD Anderson Cancer Center, Joint Venture
  • University of Texas MD Anderson Cancer Center, Key Competitors
  • University of Texas MD Anderson Cancer Center, Recent Deals Summary

Samples

Loading
LOADING...

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Baylor St Luke's Medical Center
  • TIRR Memorial Hermann
  • Houston Methodist Hospital
  • Cancer Therapy and Research Center
  • Texas Children's Cancer Center